Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Esther Obeng

Has grant

Associate Professor

Emory University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Recent Grants

Grant: Close

Dissecting the impact of clonal hematopoiesis on adverse outcomes in pediatric cancer survivors

Open Date: 2022-07-01

Close Date: 2026-06-30

Articles (14)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (6)

Rashid Mehmood

Senior Scientist

St. Jude Children's Research Hospital

UNITED STATES

View details

Csaba P. Kovesdy

UNITED STATES

View details

Thomas Pfeiffer

Assistant Professor

Washington University in Saint Louis School of Medicine

UNITED STATES

View details

John Choi

The University of Alabama

UNITED STATES

View details

Mireya Velasquez

St. Jude Children's Research Hospital

UNITED STATES

View details

ami shah

Clinical Professor of Pediatrics

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Esther Obeng

Research Interests

Explore related searches

Recent Grants

Articles (14)

Clonal Hematopoiesis in Kidney Disease

Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Mortality in Patients with ESKD

An AML-associated mutation in DNMT3A gives rise to hyperactive T cells with alloimmune and anti-leukemic activity

Dnmt3a-mutant hematopoietic stem cells generate alloreactive T cells with graft vs host disease and graft vs

Defusing AML: targeting t(8;21) forces myeloid maturation

Donor lymphocyte infusions after HCT are associated with low risk of graft-versus-host disease in pediatric and young adult patients

Disruption of cotranscriptional splicing suggests RBM39 is a therapeutic target in acute lymphoblastic leukemia

Memory T-cell enriched haploidentical transplantation with NK cell addback results in promising long-term outcomes: a phase II trial

RNA splicing as a therapeutic target in myelodysplastic syndromes

Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemia

Noncoding rules of survival: epigenetic regulation of normal and malignant hematopoiesis.

SF3B1 mutation and ATM deletion codrive leukemogenesis via centromeric R-loop dysregulation.

Venetoclax-based therapy as a bridge to allogeneic hematopoietic cell transplantation in children with relapsed/refractory AML.

Collaborators (6)

Rashid Mehmood

Csaba P. Kovesdy

Thomas Pfeiffer

John Choi

Mireya Velasquez

ami shah

Make your next move.